The technique of turning off solid tumor tissue as a substitute for surgery at Fuda Cancer Hospital in Guangzhou, China becomes a treatment choice for Indonesian citizens who suffer from cancer
GUANGZHOU, China, Nov. 26, 2018 /PRNewswire/ -- Receiving disease treatments abroad has become the choice of many Indonesian citizens lately. The reasons vary, from better service to promising technology and a higher percentage of cure. The Indonesia Services Dialogue (ISD) noted that the number of Indonesians seeking for treatment abroad has increased by almost 100% over the past 10 years. If in 2006 there were 350 thousand patients, in 2015 it jumped to 600 thousand patients. Cancer patients are no exception.
Fuda Cancer Hospital in Guangzhou, China, receives no less than 500 patients from Indonesia each year. Most of them come to treat breast cancer. Similar in China, breast cancer is the biggest cause of death for women in Indonesia. "The highest number of cases for woman is definitely breast cancer. While lung cancer in women and men are also high, and then followed by cervical cancer and liver cancer," said Dr. Luo Rongcheng, Managing Director of the Fuda Cancer Hospital.
Fuda offers a cancer treatment method called 3C + P (cryosurgical ablation (CSA), cancer microsphere intervention (CMI), combined immunotherapy for cancer (CIC) and personalized treatment) with minimal invasive advantages. This method has been approved by the United States Food and Drug Administration (FDA) since 1998 and the Chinese Food and Drug Administration in 1999. More than 10,000 cryotherapy ablation cases have been performed at the Cancer Hospital Fuda since 2000.
Among the 10,000 cases, 85 percent have experienced faster recovery process, faster handling process than in surgeries, chemotherapies, or radiations, slower cancer cell metastases, without vomiting, nausea or other traditional effects commonly found in chemotherapy and radiation. Cryotherapy is suitable for cancer cases that are no longer possible to undergo surgery because of age, the rate of spread is already high, and the risk of surgery.
The management of Fuda Cancer Hospital, Shi Jian, further stated that Indonesia, the Philippines, Malaysia and Thailand have become the four Southeast Asian countries which had a significant amount of patients going to the hospital. He explained that the deployment of unconventional methods may be a reason for attracting many local and international patients. The hospital has received a Joint Commission International (JCI) accreditation since March 2011.
The World Health Organization (WHO) estimates that there will be an 'explosion' in the number of people with cancer in 2030. Based on the data from the 2013 Basic Health Research (Riskesdas), the prevalence of tumors or cancer in Indonesia is 1.4 per 1,000 residents or around 330,000 people. Meanwhile, according to GLOBOCAN 2018 data, there are an estimated 348,809 cancer incidents and 207,210 cancer deaths in Indonesia, where the incidence rate is estimated to increase to 36% in 2030.